Literature DB >> 9867309

The glutamate hypothesis of schizophrenia.

S Akhondzadeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9867309     DOI： 10.1046/j.1365-2710.1998.00160.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN： 0269-4727            Impact factor:   2.512


× No keyword cloud information.
  2 in total

1.  Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.

Authors:  Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein Modabbernia; Azad Maroufi; Gholam-Reza Esfandiari; Mehrangiz Naderi; Fariba Ghebleh; Mina Tabrizi; Shams-Ali Rezazadeh
Journal:  Psychopharmacology (Berl)       Date:  2010-10-15       Impact factor: 4.530

2.  A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Authors:  Shahin Akhondzadeh; Hamid Tajdar; Mohammad-Reza Mohammadi; Mohammad Mohammadi; Gholam-Hossein Nouroozinejad; Omid L Shabstari; Hossein-Ali Ghelichnia
Journal:  Child Psychiatry Hum Dev       Date:  2007-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.